Traders Buy High Volume of Call Options on Novo Nordisk A/S (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors acquired 56,398 call options on the company. This represents an increase of approximately 35% compared to the average daily volume of 41,
9hon MSN
The final trades of the day with CNBC’s Melissa Lee and the Fast Money traders. The murderous doll who captivated pop culture ...
Novo Nordisk stock gains as it reports better-than-expected fourth-quarter 2024 results driven by strong sales of Diabetes ...
American depositary receipts (ADRs) of Novo Nordisk (NVO) jumped over 4% in pre-market trading this morning after reporting a healthy sales ...
Novo Nordisk is a healthcare company focused on the research, development, manufacturing, and distribution of pharmaceutical products globally. During the relevant period, Novo Nordisk was conducting ...
1d
Novo Nordisk AS (NVO) reports a strong 26% increase in sales and operating profit, with significant growth in obesity care ...
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
Investors in Novo-Nordisk AS (Symbol: NVO) saw new options become available today, for the March 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVO ...
Short NVO slightly under 88.18, target n/a, stop loss @ 88.43 Check the time stamp on this data. Updated AI-Generated Signals for Novo Nordisk A/s (NVO) available here: NVO. Type a few symbols and ...
Novo Nordisk (NVO) stock in focus as company announces new Phase 3 trial for its next-gen weight loss drug CagriSema despite ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback